MedPath

The Effects of Stair Climbing on Arterial Stiffness, Blood Pressure and Leg Strength in Stage-1 Postmenopausal Women

Not Applicable
Completed
Conditions
Hypertension
Menopause
Interventions
Behavioral: Stair climbing
Registration Number
NCT03254251
Lead Sponsor
Pusan National University
Brief Summary

We used a parallel experimental design. Following an initial screening and familiarization session of study tests and procedures, eligible postmenopausal women were randomly assigned to a stair climbing (SC) group or non-exercising control group. SC training session was progressive program, and was performed 4 days a week for 12 weeks. Measurements were collected at baseline and after 12 weeks during the same time of day (±1 hour) in the morning following an overnight fast and abstinence from caffeinated drinks, alcohol, and between 48 and 72 hours after the last exercise session.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
41
Inclusion Criteria
  • Stage-1 hypertension
  • Postmenopausal
Exclusion Criteria
  • Pulmonary, renal, adrenal, pituitary, severe psychiatric, thyroid, or cardiovascular disease other than stage-1 systolic hypertension (140-159 mmHg)
  • Hormone replacement therapy during the 6 months prior the study
  • Smoker or having any medication changes in the previous year
  • Experience with psychological and physical therapy in the previous year
  • History of steady exercise or exercise training in the last year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stair Climbing (SC)Stair climbingN=20, 12 weeks of stair climbing exercise training.
Primary Outcome Measures
NameTimeMethod
Body mass index (BMI)12 weeks

BMI was calculated as weight/height\^2 (kg/m\^2)

Heart rate (HR)12 weeks

Heart rate was measured by ECG

Muscle strength12 weeks

Muscle strength was measured by the eight repetition maximum (8RM) test using extension machine (Cyber 6000).

Arterial stiffness12 weeks

Arterial stiff ness was measured by brachial to ankle pulse wave velocity (baPWV, m/s) using volume plethysmographic device (VP-1000).

Body composition12 weeks

Body composition was measured using eight-polar tactile-electrode impedance meter (InBody 720). Body weight (kg), fat mass (kg), and fat free mass (kg) were assessed.

Blood pressure (BP)12 weeks

BP (mmHg) was measured by volume plethysmographic device. Diastolic blood pressure and systolic blood pressure were measured.

Height12 weeks

Height (m) was measured with a stadiometer

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath